Annual D&A
$2.60 M
+$1.08 M+70.87%
December 31, 2024
Summary
- As of March 10, 2025, ARQT annual depreciation & amortization is $2.60 million, with the most recent change of +$1.08 million (+70.87%) on December 31, 2024.
- During the last 3 years, ARQT annual D&A has risen by +$2.15 million (+472.47%).
- ARQT annual D&A is now at all-time high.
Performance
ARQT Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$458.00 K
-$974.00 K-68.02%
December 31, 2024
Summary
- As of March 10, 2025, ARQT quarterly depreciation & amortization is $458.00 thousand, with the most recent change of -$974.00 thousand (-68.02%) on December 31, 2024.
- Over the past year, ARQT quarterly D&A has stayed the same.
- ARQT quarterly D&A is now -68.02% below its all-time high of $1.43 million, reached on September 30, 2024.
Performance
ARQT Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$2.60 M
+$73.00 K+2.89%
December 31, 2024
Summary
- As of March 10, 2025, ARQT TTM depreciation & amortization is $2.60 million, with the most recent change of +$73.00 thousand (+2.89%) on December 31, 2024.
- Over the past year, ARQT TTM D&A has stayed the same.
- ARQT TTM D&A is now at all-time high.
Performance
ARQT TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
ARQT Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +70.9% | 0.0% | 0.0% |
| 3 y3 years | +472.5% | +18.4% | +75.3% |
| 5 y5 years | +3722.1% | +18.4% | +75.3% |
ARQT Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +472.5% | -68.0% | +236.8% | at high | +472.5% |
| 5 y | 5-year | at high | +3722.1% | -68.0% | +1808.3% | at high | +3722.1% |
| alltime | all time | at high | -100.0% | -68.0% | >+9999.0% | at high | >+9999.0% |
Arcutis Biotherapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $2.60 M(+70.9%) | $458.00 K(-68.0%) | $2.60 M(+2.9%) |
| Sep 2024 | - | $1.43 M(+308.0%) | $2.53 M(+70.6%) |
| Jun 2024 | - | $351.00 K(-2.0%) | $1.48 M(-2.3%) |
| Mar 2024 | - | $358.00 K(-7.0%) | $1.52 M(-0.3%) |
| Dec 2023 | $1.52 M(+62.8%) | $385.00 K(-0.5%) | $1.52 M(+2.6%) |
| Sep 2023 | - | $387.00 K(+0.3%) | $1.48 M(+7.6%) |
| Jun 2023 | - | $386.00 K(+6.3%) | $1.38 M(+20.1%) |
| Mar 2023 | - | $363.00 K(+4.6%) | $1.15 M(+22.8%) |
| Dec 2022 | $934.00 K(+105.7%) | $347.00 K(+23.0%) | $934.00 K(+29.2%) |
| Sep 2022 | - | $282.00 K(+81.9%) | $723.00 K(+29.8%) |
| Jun 2022 | - | $155.00 K(+3.3%) | $557.00 K(+10.1%) |
| Mar 2022 | - | $150.00 K(+10.3%) | $506.00 K(+11.5%) |
| Dec 2021 | $454.00 K | $136.00 K(+17.2%) | $454.00 K(+28.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $116.00 K(+11.5%) | $353.00 K(+32.2%) |
| Jun 2021 | - | $104.00 K(+6.1%) | $267.00 K(+38.3%) |
| Mar 2021 | - | $98.00 K(+180.0%) | $193.00 K(+58.2%) |
| Dec 2020 | $122.00 K(+79.4%) | $35.00 K(+16.7%) | $122.00 K(+9.9%) |
| Sep 2020 | - | $30.00 K(0.0%) | $111.00 K(+11.0%) |
| Jun 2020 | - | $30.00 K(+11.1%) | $100.00 K(+40.8%) |
| Mar 2020 | - | $27.00 K(+12.5%) | $71.00 K(+4.4%) |
| Dec 2019 | $68.00 K(>+9900.0%) | $24.00 K(+26.3%) | $68.00 K(+54.5%) |
| Sep 2019 | - | $19.00 K(+1800.0%) | $44.00 K(+76.0%) |
| Jun 2019 | - | $1000.00(-95.8%) | $25.00 K(+4.2%) |
| Mar 2019 | - | $24.00 K | $24.00 K |
| Dec 2018 | $0.00(0.0%) | - | - |
| Dec 2017 | $0.00 | - | - |
FAQ
- What is Arcutis Biotherapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics annual D&A year-on-year change?
- What is Arcutis Biotherapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics quarterly D&A year-on-year change?
- What is Arcutis Biotherapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Arcutis Biotherapeutics?
- What is Arcutis Biotherapeutics TTM D&A year-on-year change?
What is Arcutis Biotherapeutics annual depreciation & amortization?
The current annual D&A of ARQT is $2.60 M
What is the all time high annual D&A for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high annual depreciation & amortization is $2.60 M
What is Arcutis Biotherapeutics annual D&A year-on-year change?
Over the past year, ARQT annual depreciation & amortization has changed by +$1.08 M (+70.87%)
What is Arcutis Biotherapeutics quarterly depreciation & amortization?
The current quarterly D&A of ARQT is $458.00 K
What is the all time high quarterly D&A for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high quarterly depreciation & amortization is $1.43 M
What is Arcutis Biotherapeutics quarterly D&A year-on-year change?
Over the past year, ARQT quarterly depreciation & amortization has changed by $0.00 (0.00%)
What is Arcutis Biotherapeutics TTM depreciation & amortization?
The current TTM D&A of ARQT is $2.60 M
What is the all time high TTM D&A for Arcutis Biotherapeutics?
Arcutis Biotherapeutics all-time high TTM depreciation & amortization is $2.60 M
What is Arcutis Biotherapeutics TTM D&A year-on-year change?
Over the past year, ARQT TTM depreciation & amortization has changed by $0.00 (0.00%)